Molecular docking analysis shows stable binding between berberine and the EGFR target, although no significant differences in EGFR mRNA levels were observed in the brain tissues of AD model mice (3 × Tg AD mice) (Wei et al., 2023). This evidence concerns the gene EGFR and Alzheimer disease.